Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Liên Minh Châu Âu - Tiếng Anh - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human - vaccines - active immunisation against h5n1 subtype of influenza a virus.; this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain.; prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Liên Minh Châu Âu - Tiếng Anh - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human, immunization, disease outbreaks - vaccines, - active immunisation against h5n1 subtype of influenza a virus., this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain., prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.,

SC HEALTH INSTANT HAND SANITIZER- alcohol gel Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

sc health instant hand sanitizer- alcohol gel

sc health spv, llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - for hand sanitizing to decrease bacteria on the skin.

SC HEALTH ANTIBACTERIAL WIPES- benzalkonium chloride cloth Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

sc health antibacterial wipes- benzalkonium chloride cloth

sc health spv, llc - benzalkonium chloride 0.1%, antibacterial - for hand sanitizing to decrease bacterial on the skin.  recommended for repeat use

SC HEALTH HAND SANITIZER GEL SINGLE USE PACKETS- alcohol gel Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

sc health hand sanitizer gel single use packets- alcohol gel

sc health spv, llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - for hand sanitizing to decrease bacterial on the skin. 

SC HEALTH HAND SANITIZER- alcohol spray, metered Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

sc health hand sanitizer- alcohol spray, metered

sc health spv, llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - for hand-washing to decrease bacteria on the skin, only when water is not available.

Herceptin SC New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

herceptin sc

roche products (nz) ltd - trastuzumab 120 mg/ml - solution for injection - 600 mg/5ml - active: trastuzumab 120 mg/ml excipient: histidine histidine hydrochloride monohydrate hyaluronidase methionine polysorbate 20 trehalose dihydrate water for injection - herceptin sc is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress her2: a) as monotherapy for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease; or b) in combination with taxanes for the treatment of those patients who have not received chemotherapy for their metastatic disease; or c) in combination with an aromatase inhibitor for the treatment of post-menopausal patients with hormone-receptor positive metastatic breast cancer.

Mabthera SC New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

mabthera sc

roche products (nz) ltd - rituximab 1600mg;   - solution for injection - 1600mg/13.4ml - active: rituximab 1600mg   excipient: histidine histidine hydrochloride methionine polysorbate 80 trehalose dihydrate vorhyaluronidase alfa water for injection - mabthera sc 1600 mg in combination with chemotherapy is indicated for the treatment of patients with chronic lymphocytic leukaemia

MABTHERA SC rituximab (rch) 1600 mg/13.4 mL solution for injection vial Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

mabthera sc rituximab (rch) 1600 mg/13.4 ml solution for injection vial

roche products pty ltd - rituximab, quantity: 1600 mg - injection - excipient ingredients: vorhyaluronidase alfa; histidine; histidine hydrochloride; trehalose dihydrate; methionine; polysorbate 80; water for injections - mabthera sc 1600 mg is indicated for the treatment of patients with cd20 positive chronic lymphocytic leukaemia (cll) in combination with chemotherapy.

MABTHERA SC rituximab (rch) 1400 mg/11.7 mL solution for injection vial Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

mabthera sc rituximab (rch) 1400 mg/11.7 ml solution for injection vial

roche products pty ltd - rituximab, quantity: 1400 mg - injection - excipient ingredients: vorhyaluronidase alfa; histidine; histidine hydrochloride; trehalose dihydrate; methionine; polysorbate 80; water for injections - mabthera sc is indicated for treatment of patients with: - cd20 positive, previously untreated, stage iii/iv follicular, b-cell non-hodgkin's lymphoma, - cd20 positive, relapsed or refractory low grade or follicular, b-cell non-hodgkin's lymphoma, - cd 20 positive, diffuse large b-cell non-hodgkin's lymphoma, in combination with chemotherapy.